April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
The Indianapolis Glaucoma Progression Study: Reproducibility of Color Doppler Imaging
Author Affiliations & Notes
  • M. A. Pickett
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • A. Harris
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • B. Siesky
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • R. Ehrlich
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • A. Moss
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • L. Cantor
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • L. McCranor
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • J. Abrams
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • D. WuDunn
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • Footnotes
    Commercial Relationships  M.A. Pickett, None; A. Harris, None; B. Siesky, None; R. Ehrlich, None; A. Moss, None; L. Cantor, None; L. McCranor, None; J. Abrams, None; D. WuDunn, None.
  • Footnotes
    Support  Pfizer and Research to Prevent Blindness (RPB)
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5864. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. A. Pickett, A. Harris, B. Siesky, R. Ehrlich, A. Moss, L. Cantor, L. McCranor, J. Abrams, D. WuDunn; The Indianapolis Glaucoma Progression Study: Reproducibility of Color Doppler Imaging. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5864.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the reproducibility of color Doppler imaging (CDI) measurements performed on primary open angle glaucoma (OAG) patients participating in the Indianapolis Glaucoma Progression Study (IGPS).

Methods: : Retrobulbar blood flow velocities and Pourcelot’s vascular resistance index (RI) in OAG patients were measured with CDI as part of the IGPS. Two baseline measurements were obtained 1-2 weeks apart at the same time of day for all participants. Peak systolic and end diastolic blood flow velocities (PSV/EDV) were measured in the ophthalmic (OA), central retinal (CRA), and nasal and temporal short posterior ciliary arteries (N/TPCA) and RI was calculated. Reproducibility of CDI was assessed by estimating the intra-class correlation coefficient (ICC) and 95% confidence intervals (CI) between the two measurements. Limits of agreement were determined for quantifying the stability of the data. Bland-Altman plots of the difference between the two measurements versus the average of the two measurements for each parameter were created.

Results: : 93 patients were examined to date with a mean age of 65.8 (SD9.9) years (58% female). In the OA the ICC for the PSV, EDV, and RI were 0.939 (0.908-0.959), 0.885 (0.826-0.923), and 0.914 (0.870-0.943), respectively. In the CRA the ICC for the PSV, EDV, and RI were 0.882 (0.822-0.922), 0.763 (0.642-0.843), and 0.900 (0.849-0.943). The ICC for the PSV, EDV and RI were 0.931 (0.896-0.954), 0.902 (0.852-0.935), 0.835 (0.751-0.890) in the NPCA and 0.927 (0.891-0.952), 0.934 (0.901-0.956), 0.919 (0.877-0.946) in the TPCA, respectively. Natural variation was largest for OA PSV (4.0) and smallest for TPCA RI (0.028).

Conclusions: : In this study CDI measurements of the OA, CRA and PCAs conducted at one to two week intervals were shown to be highly reproducible. The analysis suggests a trained CDI operator can reliably measure the retrobulbar blood vessels in OAG patients.

Keywords: blood supply • imaging/image analysis: non-clinical • clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×